LifeWalker Upright Walker vs. Conventional Rollator Walker and Predicate Device
LifeWalker Upright Walker Versus Conventional Rollator Walker and Predicate Device
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this project is to evaluate if the LifeWalker Upright walker is improves walking and reports of pain compared to a conventional rollator and predicate walker device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 25, 2016
CompletedFirst Posted
Study publicly available on registry
November 18, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2019
CompletedResults Posted
Study results publicly available
September 6, 2019
CompletedSeptember 6, 2019
August 1, 2019
2.8 years
October 25, 2016
May 22, 2019
August 15, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
6 Minute Walk Test
The 6 minute walk test is performed as an objective evaluation of functional exercise capacity. The 6minute walk test is easy to administer, well tolerated, and typically reflective of activities of daily living. The test measures the distance that the patient can walk on a flat, hard surface, indoors, in a period of 6 minutes. The walk test is patient self-paced and assesses the level of functional capacity. Patients are allowed to stop and rest during the test, however, the timer does not stop. If the patient is unable to complete the time, the time stopped is noted and reason for stopping prematurely is recorded. The number of stops and stumbles will be recorded during the test. This test will be administered while wearing a mask to measure oxygen consumption in addition to blood pressure, heart rate and oxygen saturation.
One testing session
Secondary Outcomes (6)
10 Meter Walk Test
One testing session
Baseline Modified Falls Efficacy Scale (mFES) Score:
Baseline score taken at first session
Visual Analog Pain Scale (VAS)
Baseline score taken at first session
User Functional Rating Scale
One testing session
Borg Rate of Perceived Exertion
One testing session
- +1 more secondary outcomes
Study Arms (3)
Started with Forearm Support Walker (LW Upright)
EXPERIMENTALData collection began with participants using the LifeWalker Upright Walker then using the two remaining walkers in a randomized order
Standard Rollator Walker (Control)
EXPERIMENTALData collection began with participants using a conventional standard rollator (SR) walker then using the two remaining walkers in a randomized order
Predicate Device (PD)
EXPERIMENTALData collection began with participants using their own rollator walkers then using the two remaining walkers in a randomized order
Interventions
LifeWalker (LW) upright walker
Individual's personal walker
A control rollator device
Eligibility Criteria
You may qualify if:
- Individuals who use a walker due to back pain or adults (over 18) who use a walker for ambulation.
- Ages from 18 to 89 years old
- Medically stable for therapy
You may not qualify if:
- Patient weight exceeds 300 lbs
- Patient height is below 5'0" or exceeds 6'3"
- Inactive, physically unfit to fit into the device.
- Cognitive deficits or visual impairment that would impair their ability to give informed consent or to follow simple instructions during the experiments.
- Mini-Mental State Exam (MMSE) score below 17
- Pregnant women
- Co-morbidity that interferes with the study (e.g. stroke, pace maker placement, severe ischemia cardiac disease, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rehabilitation Institute of Chicago
Chicago, Illinois, 60611, United States
Related Publications (1)
Jayaraman C, Mummidisetty CK, Loesch A, Kaur S, Hoppe-Ludwig S, Staat M, Jayaraman A. Postural and Metabolic Benefits of Using a Forearm Support Walker in Older Adults With Impairments. Arch Phys Med Rehabil. 2019 Apr;100(4):638-647. doi: 10.1016/j.apmr.2018.10.001. Epub 2018 Oct 24.
PMID: 30367875DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
All assessments were done on level ground surfaces, all tests were done in controlled, clinical environment. Long term effects of using LifeWalker could not be determined in this study. The pathological demographic of the study sample was diverse.
Results Point of Contact
- Title
- Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes
- Organization
- Rehabilitation Institute of Chicago
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 25, 2016
First Posted
November 18, 2016
Study Start
June 1, 2016
Primary Completion
April 1, 2019
Study Completion
April 1, 2019
Last Updated
September 6, 2019
Results First Posted
September 6, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share